AI Portfolio Summary
In 2025 Q4, KVP Capital Advisors, LP maintained a portfolio of 27 distinct positions. The most significant new addition to the portfolio was TERNS PHARMACEUTICAL, which now represents 17.20% of the total fund value.
Total Positions
27
Quarter
2025 Q4
Top Holding
TERN (17.2%)
Top 10 Concentration
68.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-27 of 27
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERN
TERNS PHARMACEU...
|
Healthcare | 17.20% | — |
#1
Prev: #—
|
9.5 | 440,000 | no change |
NEW
|
440,000 | $17,776,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 12.24% | — |
#2
Prev: #—
|
9.0 | 42,900 | no change |
NEW
|
42,900 | $12,644,346 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 6.40% | — |
#3
Prev: #—
|
7.1 | 36,200 | no change |
NEW
|
36,200 | $6,611,568 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
JAZZ PHARMACEUT...
|
—
|
CALL Option | 5.10% | — |
#4
Prev: #—
|
6.0 | 31,000 | no change |
NEW
|
31,000 | $5,270,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 5.07% | — |
#5
Prev: #—
|
6.0 | 2,165,997 | no change |
NEW
|
2,165,997 | $5,241,714 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 5.02% | — |
#6
Prev: #—
|
5.5 | 414,000 | no change |
NEW
|
414,000 | $5,183,280 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 4.80% | — |
#7
Prev: #—
|
5.4 | 28,497 | no change |
NEW
|
28,497 | $4,959,618 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 4.48% | — |
#8
Prev: #—
|
5.3 | 53,000 | no change |
NEW
|
53,000 | $4,629,020 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 4.48% | — |
#9
Prev: #—
|
5.3 | 58,250 | no change |
NEW
|
58,250 | $4,625,633 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 3.71% | — |
#10
Prev: #—
|
5.0 | 121,524 | no change |
NEW
|
121,524 | $3,832,867 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVRA
SAVARA INC
|
Healthcare | 3.53% | — |
#11
Prev: #—
|
4.9 | 605,280 | no change |
NEW
|
605,280 | $3,649,838 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 3.36% | — |
#12
Prev: #—
|
4.8 | 91,000 | no change |
NEW
|
91,000 | $3,477,110 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.19% | — |
#13
Prev: #—
|
4.8 | 133,000 | no change |
NEW
|
133,000 | $3,300,395 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 2.88% | — |
#14
Prev: #—
|
4.7 | 17,500 | no change |
NEW
|
17,500 | $2,975,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 2.67% | — |
#15
Prev: #—
|
4.6 | 59,700 | no change |
NEW
|
59,700 | $2,764,110 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.24% | — |
#16
Prev: #—
|
4.4 | 4,750 | no change |
NEW
|
4,750 | $2,314,438 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 2.22% | — |
#17
Prev: #—
|
4.4 | 462,355 | no change |
NEW
|
462,355 | $2,297,904 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.12% | — |
#18
Prev: #—
|
4.3 | 27,500 | no change |
NEW
|
27,500 | $2,190,375 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.92% | — |
#19
Prev: #—
|
4.3 | 45,000 | no change |
NEW
|
45,000 | $1,982,250 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.60% | — |
#20
Prev: #—
|
4.1 | 32,700 | no change |
NEW
|
32,700 | $1,655,928 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
FULCRUM THERAPE...
|
—
|
CALL Option | 1.21% | — |
#21
Prev: #—
|
4.0 | 110,900 | no change |
NEW
|
110,900 | $1,254,279 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 1.17% | — |
#22
Prev: #—
|
4.0 | 230,423 | no change |
NEW
|
230,423 | $1,205,112 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.10% | — |
#23
Prev: #—
|
3.9 | 26,900 | no change |
NEW
|
26,900 | $1,137,332 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 1.07% | — |
#24
Prev: #—
|
3.9 | 505,431 | no change |
NEW
|
505,431 | $1,106,894 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.55% | — |
#25
Prev: #—
|
3.7 | 50,000 | no change |
NEW
|
50,000 | $565,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.39% | — |
#26
Prev: #—
|
3.7 | 4,000 | no change |
NEW
|
4,000 | $398,960 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VYNE
VYNE THERAPEUTI...
|
Healthcare | 0.28% | — |
#27
Prev: #—
|
3.6 | 500,551 | no change |
NEW
|
500,551 | $290,370 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-27 of 27 holdings